This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Guelph directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment.
International journal of molecular sciences · 2026
Bridging the gap: an emerging link between tubulinopathies and ciliopathies.
NPJ genomic medicine · 2026
Latest funding
- $430,833
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis
CIHR · 2024 · Nominated PI
2 publications.
Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment.
Steiman S, Kinsella C, Zhang Y, Omer S, Brown C, Forguson G, Elbakr L, Pastore S, Ivakine EA
Bridging the gap: an emerging link between tubulinopathies and ciliopathies.
Steiman S, Omer S, Pastore S, Ivakine EA
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis
Principal investigators: Omer, Safia
Keywords: Chlamydia Trachomatis; Sexually Transmitted Infection
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.